Here are three things to know.
- The valve is intended for use in surgical aortic valve replacement.
- The implant features anticalcification tissue properties, an expandable frame and capabilities for future valve-in-valve procedures.
- Edwards’ Lifesciences will launch the heart valve in early 2018.
More articles on supply chain:
Precision benchmarking a panacea for purchased services savings
Vertex Pharma makes 1st price hike on cystic fibrosis drug
Novo Nordisk recalls insulin pen cartridge holders
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
